Lista de obras -

A Case of Palpitations Due to T-Wave Oversensing Caused by Sacubitril/Valsartan

scientific article published on 05 April 2018

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

artículo científico publicado en 2020

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction

artículo científico publicado en 2020

Clinical Experience With the Use of Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis

artículo científico publicado en 2019

Current state of cardiac amyloidosis ⬇️

artículo científico publicado el 1 de marzo de 2013

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

artículo científico publicado en 2019

Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States

artículo científico publicado en 2013

Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF

scientific article published on 04 September 2020

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

artículo científico publicado en 2020

Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction

artículo científico publicado en 2007

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)

artículo científico publicado en 2020

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

artículo científico publicado en 2020

Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial

artículo científico publicado en 2012

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial

artículo científico publicado en 2009

Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).

artículo científico publicado en 2016

Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).

artículo científico publicado en 2013

HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HR

artículo científico publicado en 2008

HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations

artículo científico publicado en 2008

Hospitalization for Acute Heart Failure Syndromes ⬇️

artículo científico publicado el 28 de septiembre de 2011

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

artículo científico publicado en 2016

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults

artículo científico publicado en 2017

Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction, GALACTIC-HF: Baseline Characteristics and Comparison with Contemporary Clinical Trials

artículo científico publicado en 2020

Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION])

artículo científico publicado en 2009

Response to The J-Point Revisited

Should We Perform a Heart Failure Risk Score? ⬇️

artículo científico publicado el 1 de enero de 2013

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy

artículo científico publicado en 2010

The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy

article

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy

artículo científico publicado en 2012

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

artículo científico

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

artículo científico publicado en 2014

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

artículo científico

The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study

artículo científico publicado en 2014

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice

artículo científico

The Effect of Comorbidity on the Competing Risk of Sudden and Nonsudden Death in an Ambulatory Heart Failure Population ⬇️

artículo científico publicado el 1 de marzo de 2011

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

artículo científico publicado en 2006

Lista de obras de

A Case of Palpitations Due to T-Wave Oversensing Caused by Sacubitril/Valsartan

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction

Clinical Experience With the Use of Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis

Current state of cardiac amyloidosis ⬇️

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States

Effect of Dapagliflozin on Outpatient Worsening of Patients with Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial

Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).

Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).

HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HR

HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations

Hospitalization for Acute Heart Failure Syndromes ⬇️

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults

Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction, GALACTIC-HF: Baseline Characteristics and Comparison with Contemporary Clinical Trials

Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION])

Response to The J-Point Revisited

Should We Perform a Heart Failure Risk Score? ⬇️

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy

The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice

The Effect of Comorbidity on the Competing Risk of Sudden and Nonsudden Death in an Ambulatory Heart Failure Population ⬇️

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).